ANAX 5.5 Spinal System
Orthosis, Spondylolisthesis Spinal Fixation. 510(k) K143417, from U&I Corporation (Uijeongbu-Si, KR). Product code MNH, class 2.
As of Nov 17, 2026, K143417 is an FDA 510(k) held by U&I Corporation, substantially equivalent on Feb 25, 2015 after 89 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Feb 25, 2015
- Review time: 89 days
- Recalls: 0
- Cited as a predicate by: 3 devices
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFANAX 5.5 Spinal System is a posterior, noncervical pedicle fixation system intended to provide immobilization and stabilization of spinal segments in skeletally-mature patients as an adjunct to fusion by autogenous bone graft in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar and sacral spine: • Spondylolisthesis (Grade 3 and 4) • Degenerative…
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Optima, Spinal SystemK024096 · U&I Corp., America · Mar 12, 2003
- Fixpine Ii SystemK100765 · Dio Medical Co., Ltd. · Jul 19, 2010
- Anax 5.5 Spinal SystemK132101 · U&I Corporation · Nov 25, 2013
Cited as a Predicate
3 later 510(k) summaries name this device as a predicate- INNOVERSE Spinal SystemK233960 · Innosys Co., Ltd. · Feb 6, 2024
- ANAX™ 5.5 Spinal SystemK231737 · Innosys Co., Ltd. · Oct 26, 2023
- ANAX™ 5.5 Spinal SystemK162189 · U&I Corporation · Aug 30, 2016
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 28, 2014
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3070
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files